The following discussion summarizes the significant factors affecting the
operating results, financial condition, liquidity and cash flows of our Company
as of and for the periods presented below. The following discussion and analysis
should be read in conjunction with the audited consolidated financial statements
and the accompanying notes thereto, included elsewhere within this Annual
Report. The statements in this discussion regarding industry outlook, our
expectations regarding our future performance, liquidity and capital resources
and all other non-historical statements in this discussion are forward-looking
statements and are based on the beliefs of our management, as well as
assumptions made by, and information currently available to, our management and
are made as of the date of this Annual Report. See "Cautionary Note Regarding
Forward-Looking Statements." Actual results could differ materially from those
discussed in or implied by forward-looking statements as a result of various
factors, including those discussed below and elsewhere within this Annual
Report, particularly in Item 1A-"Risk Factors." Definitions of capitalized terms
not defined herein appear in the notes to our consolidated financial statements.

                                       39

  Table of Contents

                                2021 Highlights

For the year ended December 31, 2021, we had net income from continuing
operations of $279.6 million and Adjusted EBITDA of $729.4 million. The
Company's legacy businesses performed very well throughout 2021, and were
further supplemented by our acquisitions in the Engineered Materials segment.
These very strong results were achieved, despite challenging industry operating
conditions that arose during the second half of the year, including high utility
costs and constraints in material, labor and energy. Additionally, the Company
delivered strong cash generation during 2021 and returned significant cash to
our shareholders, purchasing approximately 1.0 million ordinary shares for total
value of $50.0 million and declaring quarterly dividends for an aggregate value
of $0.80 per ordinary share, or $31.4 million. Refer to the discussion below for
further information and refer to "Non-GAAP Performance Measures" for discussion
of our use of non-GAAP measures in evaluating our performance and a
reconciliation of these measures. Highlights for the year are described below.

Portfolio Transformation: In 2021, we made significant strides in the Company's
strategy to transform into a higher growth, higher margin and less cyclical
specialty and sustainable materials provider. Key achievements in this
transformation during the year include the following (refer to Note 4 and 5 in
the consolidated financial statements for further information):

Acquisition of the PMMA Business - On May 3, 2021, the Company closed on the

PMMA Acquisition for a purchase price of $1,364.9 million, funded primarily

using proceeds from new debt financing arrangements, as described below. PMMA

1. is a transparent and rigid plastic with a wide range of end uses, and

complements Trinseo's existing offerings across several end markets including

automotive, building & construction, medical and consumer electronics. The


    results of this business are included within the Company's Engineered
    Materials segment.

Acquisition of Aristech Surfaces - On September 1, 2021, the Company closed on

the Aristech Surfaces Acquisition for a purchase price of $449.5 million,

funded with cash on hand and existing credit facilities. Aristech Surfaces is

a leading North America manufacturer and global provider of PMMA continuous

2. cast and solid surface sheets, serving the wellness, architectural,

transportation and industrial markets. Its products are used for a variety of

applications, including the construction of hot tubs, swim spas, counter-tops,

signage, bath products and recreational vehicles. The results of this business

are included within the Company's Engineered Materials segment.

Divestiture of Synthetic Rubber Business - On December 1, 2021, the Company

completed the divestiture of our Synthetic Rubber business to Synthos S.A. and

certain of its subsidiaries (together, "Synthos") for a purchase price of

$402.4 million, which reflected reductions of approximately $41.6 million for

3. the assumption of pension liabilities by Synthos, and $47.0 million for net

working capital (excluding inventory) retained by Trinseo. The sale resulted

in the recognition of an after-tax gain of $117.8 million, which was recorded

during the fourth quarter of 2021. At closing, Trinseo and Synthos executed a

long-term supply agreement, under which we will supply Synthos with certain

raw materials used in the Synthetic Rubber business subsequent to the sale.


The assets and liabilities of our Synthetic Rubber business are classified as
held-for-sale in our prior period balance sheet and the associated operating
results of the Synthetic Rubber business are classified as discontinued
operations for all periods presented.

Exploration of Divestiture of Styrenics Businesses - In the fourth quarter of

2021, Trinseo announced that we have begun work to explore the divesture of

4. the Company's styrenics businesses, for which we launched a formal sales

process in January 2022. The scope of this potential divestiture is expected

to include the Feedstocks and Polystyrene reporting segments as well as our

50% ownership of Americas Styrenics.

Acquisition of Heathland - On December 3, 2021, the Company entered into a

definitive agreement to acquire Heathland, a leading collector and recycler of

5. post-consumer and post-industrial plastic wastes in Europe. The acquisition

closed on January 3, 2022 for a preliminary cash purchase price of €20.0

million, subject to customary working capital and other closing adjustments,


    and up to €10.0 million contingent payments to be


                                       40

  Table of Contents

  paid based on criteria as defined in the agreement. Heathland is based in
  Utrecht, the Netherlands, and is focused on converting post-consumer and

post-industrial PMMA, PC, ABS, polystyrene, and other thermoplastic waste for

use in a wide range of high-end applications. The acquisition of Heathland

aligns with Trinseo's strategy to transform into specialty materials and

sustainable solutions provider.


Capital Structure and Shareholder Return: In 2021, we executed transactions and
took steps to improve and streamline the Company's infrastructure, adjust our
capital structure to support strategic initiatives, and return value to our
shareholders. The key specific actions we took during the year in this pursuit
include:

Redomiciliation to Ireland - On October 8, 2021, we completed the cross-border

merger transaction, as approved by our shareholders at our annual meeting,

pursuant to which our former publicly-traded parent company, Trinseo S.A., a

Luxembourg limited liability company, was merged with and into Trinseo PLC, an

Irish public limited company, as successor issuer to Trinseo S.A. (the

1. "Redomiciliation"). The Redomiciliation is expected to provide Trinseo with a

favorable legal and regulatory infrastructure, simplify regulatory

requirements, provide dividend withholding tax benefits to shareholders and

provide operational efficiencies and reductions in its operating and

administrative costs. Refer to Item 1 - Business and Note 1 in the

consolidated financial statements for more information on the Redomiciliation.

Entry into New Financing Arrangements - On March 24, 2021, the Company issued

$450.0 million aggregate principal amount of 5.125% senior notes due 2029 (the

"2029 Senior Notes"). Further, on May 3, 2021, in conjunction with the closing

of the PMMA Acquisition, the Company entered into $750.0 million in

2. incremental term loan borrowings (the "2028 Term Loan B") under our existing

senior secured credit facility. The net proceeds from the 2029 Senior Notes

and the 2028 Term Loan B, as well as available cash, were used to fund the

PMMA Acquisition. Refer to Note 12 in the consolidated financial statements


    for further information.


    Share Repurchases - In December 2021, the Company's board of directors

authorized the repurchase of up to $200.0 million of the Company's ordinary

shares. Under this authority, the Company purchased approximately 1.0 million

3. ordinary shares from our shareholders through open market transactions for an

aggregate purchase price of $50.0 million (of which $1.9 million of

repurchases were not yet settled but were accrued on the consolidated balance


    sheet as of December 31, 2021).


                                       41

  Table of Contents

                             Results of Operations

Results of Operations for the Years Ended December 31, 2021, 2020, and 2019


The table below sets forth our historical results of operations, and these
results as a percentage of net sales for the periods indicated. Prior period
amounts herein have been recast in conjunction with adjustments made for the
Company's classification of the Synthetic Rubber business as discontinued
operations.

                                                          Year Ended
                                                         December 31,
(in millions)                      2021       %          2020       %           2019       %
Net sales                        $ 4,827.5    100 %    $ 2,744.6    100 %     $ 3,373.9    100 %
Cost of sales                      4,128.6     86 %      2,423.5     88 %       3,073.5     91 %
Gross profit                         698.9     14 %        321.1     12 %         300.4      9 %
Selling, general and
administrative expenses              323.4      7 %        227.5      8 %         276.9      8 %
Equity in earnings of
unconsolidated affiliates             92.7      2 %         67.0      2 %         119.0      4 %
Impairment charges                     6.8      - %         11.0      - %             -      - %
Operating income                     461.4      9 %        149.6      6 %         142.5      5 %
Interest expense, net                 79.4      2 %         43.6      2 %          39.3      1 %
Acquisition purchase price
hedge loss (gain)                     22.0      - %        (7.3)      - %             -      - %
Other expense, net                     9.5      - %          7.9      - %           3.4      - %
Income from continuing
operations before income
taxes                                350.5      7 %        105.4      4 %          99.8      4 %
Provision for income taxes            70.9      1 %         42.7      2 %          12.7      - %
Net income from continuing
operations                       $   279.6      6 %    $    62.7      2 %     $    87.1      4 %
Net income (loss) from
discontinued operations,
net of income taxes                  160.4      3 %       (54.8)    (2) %           4.9      - %
Net income                       $   440.0      9 %    $     7.9      - %     $    92.0      4 %


2021 vs. 2020

Net Sales

Of the 76% increase in net sales, 53% was due to higher selling prices resulting
mainly from the pass through of higher raw material costs. An additional 17%
increase was due to the contribution from our acquisitions in 2021, including
the PMMA Acquisition, which closed on May 3, 2021 and the Aristech Surfaces
Acquisition, which closed on September 1, 2021. Higher sales volume increased
net sales by 4%.

Cost of Sales

The 70% increase in cost of sales was primarily attributable to a 48% increase
in raw material costs, an 18% increase related to our acquisitions, and a 5%
increase from higher utility costs.

Gross Profit



The increase in gross profit of 118% was primarily attributable to higher
margins from strong demand and tight supply mainly in polystyrene, ABS, and PC,
higher volume in Latex Binders, Base Plastics and Engineered Materials, as well
as contributions from our acquisitions. See the segment discussion below for
further information.

                                       42

  Table of Contents

Selling, General and Administrative Expenses



The $95.9 million, or 42%, increase in SG&A was primarily due to an increase in
personnel costs of $42.5 million due to the Company's improved performance
during 2021 and the addition of personnel from acquisitions, as well as an
increase of $44.4 million in acquisition transaction and integration costs,
primarily related to the PMMA Acquisition and the Aristech Surfaces Acquisition.
There were additional increases of $13.8 million from costs associated with the
Company's strategic initiatives and $6.4 million attributable to foreign
exchange rate impacts. These increases were partially offset by a decrease of
$18.1 million from lower advisory and professional fees, mainly related to the
Company's transition of business and technical services from Dow in 2020.

Equity in Earnings of Unconsolidated Affiliates

The increase in equity earnings of $25.7 million was due to higher equity earnings from Americas Styrenics, mainly attributable to higher polystyrene sales volume and higher polystyrene and styrene margins in North America.

Impairment Charges

During the years ended December 31, 2021 and 2020, the Company recorded impairment charges of $6.8 million and $11.0 million, respectively, primarily related to our Boehlen styrene monomer assets. Refer to Note 14 in the consolidated financial statements for further information.

Interest Expense, Net



The increase in interest expense, net of $35.8 million, or 82%, was primarily
attributable to the Company's issuance of the 2029 Senior Notes in the first
quarter of 2021 and the 2028 Term Loan B during the second quarter of 2021.
Refer to Note 12 in the consolidated financial statements for further
information.

Acquisition purchase price hedge loss (gain)


During the years ended December 31, 2021 and 2020, the Company recorded an
acquisition purchase price hedge loss (gain) of $22.0 million and $(7.3)
million, respectively, due to the change in fair value of the Company's forward
currency hedge arrangement on the euro-denominated purchase price of the PMMA
business.

Other Expense, Net

Other expense, net for the year ended December 31, 2021 was $9.5 million, which
included $5.2 million of expense related to the non-service cost components of
net periodic benefit cost and $4.5 million of transfer taxes associated with the
PMMA Acquisition. These expense amounts were partially offset by foreign
exchange transaction gains of $1.3 million, which included $61.9 million of
foreign exchange transaction losses primarily from the remeasurement of our euro
denominated payables due to the relative changes in rates between the U.S.
dollar and the euro during the period, more than offset by $63.2 million of
gains from our foreign exchange forward contracts, excluding the acquisition
purchase price hedge. Also included in Other expense, net was $0.5 million of
loss on extinguishment of debt related to the Company's new financing
arrangements entered into during the year.

Other expense, net for the year ended December 31, 2020 was $7.9 million, which
included $5.5 million of expense related to the non-service cost components of
net periodic benefit cost and foreign exchange transaction losses of $1.9
million. Net foreign transaction losses included $24.4 million of foreign
exchange transaction gains primarily from the remeasurement of our
euro-denominated payables due to the relative changes in rates between the U.S.
dollar and the euro during the period, which were more than offset by $26.3
million of losses from our foreign exchange forward contracts, excluding the
acquisition purchase price hedge.

Provision for Income Taxes



Provision for income taxes was $70.9 million and $42.7 million for the years
ended December 31, 2021 and 2020, which resulted in an effective tax rate of 20%
and 40%, respectively. The increase in provision for income taxes was primarily
driven by the $245.1 million increase in income from continuing operations
before income taxes, partially offset by a release of a valuation allowance of
$16.3 million in 2021, as a result of improvements in business operations and
projected future results of the Company's subsidiaries in China.

                                       43

Table of Contents

Net Income (Loss) from Discontinued Operations, Net of Income Taxes


Net income (loss) from discontinued operations, net of income taxes during the
years ended December 31, 2021 and 2020 was $160.4 million and $(54.8) million,
respectively, and was related to the results of our Synthetic Rubber business,
including the divestiture of the business on December 1, 2021. This sale
resulted in the recognition of an after-tax gain of $117.8 million, which is
reflected in the results for the year ended December 31, 2021. Refer to Note 5
in the consolidated financial statements for further information.

2020 vs. 2019

Net Sales



Of the 19% decrease in net sales, 13% was due to lower selling prices resulting
mainly from the pass through of lower raw material costs. An additional 6%
decrease was due to lower sales volume, primarily within the Base Plastics and
Feedstocks segments, mainly due to the impacts related to the COVID-19 pandemic.

Cost of Sales

Of the 21% decrease in cost of sales, 16% was due to lower raw material costs, primarily from styrene and butadiene, as well as a 5% decrease due to lower sales volume primarily from the Base Plastics and Feedstocks segments.

Gross Profit

The decrease in gross profit of 7% was primarily to lower sales volumes related to COVID-19 as well as an unfavorable net raw material timing impact in comparison to the prior year. See the segment discussion below for further information.

Selling, General and Administrative Expenses


The $49.4 million, or 18%, decrease in selling, general, and administrative
expenses was due to several factors. Lower advisory and professional fees,
mainly related to the Company's transition of business and technical services
from Dow, which was largely completed in the first quarter of 2020, resulted in
a $28.2 million decrease. Also contributing to the decrease were various
management actions taken to control operating costs in response to COVID-19,
including a $9.7 million decrease in travel-related expenses, as well as a
decrease in restructuring costs of $12.5 million, primarily related to the
Company's corporate restructuring program, which was initiated in the fourth
quarter of 2019. Partially offsetting these decreases was an increase in
acquisition costs of $7.5 million, which was principally attributable to the
costs incurred in 2020 related to the proposed acquisition of the Arkema
business.

Equity in Earnings of Unconsolidated Affiliates

The decrease in equity earnings of $52.0 million was due to lower equity earnings from Americas Styrenics, mainly attributable to lower styrene margins and volume-related impacts from COVID-19 in 2020.

Impairment Charges



During the year ended December 31, 2020, the Company recorded impairment charges
of $11.0 million related to our Boehlen styrene monomer assets. There were no
impairment charges recorded during the year ended December 31, 2019. Refer to
Note 14 in the consolidated financial statements for further information.

                                       44

  Table of Contents

Interest Expense, Net

The $4.3 million, or 11%, increase in interest expense, net was primarily
attributable to a $7.4 million reduction in interest benefit recorded as a
result of the Company's entry into a new CCS arrangement in February 2020. This
was partially offset by the net decrease in interest expense of $2.6 million
attributable to lower interest rates during 2020 as compared to 2019.

Acquisition purchase price hedge loss (gain)



During the year ended December 31, 2020, the Company recorded an acquisition
purchase price hedge gain of $7.3 million due to the change in fair value of the
Company's forward currency hedge arrangement on the euro-denominated purchase
price of the PMMA business. No such gains or losses were recognized in 2019.

Other Expense, Net



Other expense, net for the year ended December 31, 2020 was $7.9 million, which
included $5.5 million of expense related to the non-service cost components of
net periodic benefit cost and foreign exchange transaction losses of $1.9
million. Net foreign transaction losses included $24.4 million of foreign
exchange transaction gains primarily from the remeasurement of our
euro-denominated payables due to the relative changes in rates between the U.S.
dollar and the euro during the period, which were more than offset by $26.3
million of losses from our foreign exchange forward contracts, excluding the
acquisition purchase price hedge.

Other expense, net for the year ended December 31, 2019 was $3.4 million, which
included $5.3 million of expense related to the non-service cost components of
net periodic benefit cost and foreign exchange transaction gains of $1.6
million. Net foreign transaction losses included $6.4 million of foreign
exchange transaction losses primarily from the remeasurement of our
euro-denominated payables due to the relative changes in rates between the U.S.
dollar and the euro during the period, which were more than offset by $8.0
million of gains from our foreign exchange forward contracts.

Provision for Income Taxes



Provision for income taxes was $42.7 million and $12.7 million for the years
ended December 31, 2020 and 2019, which resulted in an effective tax rate of 40%
and 13%, respectively. The increase in the provision for income taxes was
primarily driven by the one-time deferred tax benefit of $65.0 million recorded
in 2019 as a result of changes in the Swiss federal and cantonal tax rules. This
one-time benefit was partially offset by a $25.3 million valuation allowance for
the portion of the cantonal deferred tax asset that more likely than not will
expire before utilization. Refer to Note 15 in the consolidated financial
statements for further information. Excluding this one-time net benefit of $39.7
million in 2019, the provision for income taxes decreased $9.7 million, due
primarily to the decrease in income from continuing operations before income
taxes.

Net Income (Loss) from Discontinued Operations, Net of Income Taxes


Net income (loss) from discontinued operations, net of income taxes during the
years ended December 31, 2020 and 2019 was $(54.8) million and $4.9 million,
respectively, and was related to the results of our Synthetic Rubber business.
The results for the year ended December 31, 2020 were adversely impacted by
significant headwinds to the Synthetic Rubber business from COVID-19 impacts, as
well as impairment charges of $28.1 million recorded during the period. Refer to
Note 5 in the consolidated financial statements for further information.

Selected Segment Information



The Company's reportable segments are as follows: Engineered Materials, Latex
Binders, Base Plastics, Polystyrene, Feedstocks, and Americas Styrenics. Refer
to Item 1-Business for a description of our segments, including a detailed
overview, products and end uses, and competition and customers.

The following sections present net sales, Adjusted EBITDA, and Adjusted EBITDA
margin by segment for the years ended December 31, 2021, 2020, and 2019.
Inter-segment sales have been eliminated. Refer to Note 20 in the consolidated
financial statements for a detailed definition of Adjusted EBITDA and a
reconciliation of income from

                                       45

  Table of Contents

continuing operations before income taxes to segment Adjusted EBITDA. Beginning
in the second quarter of 2021, the Company reported the results of the Synthetic
Rubber business, as discontinued operations in the consolidated statement of
operations for all periods presented, and therefore, it is no longer presented
as a separate reportable segment. Refer to Note 5 in the consolidated financial
statements for further information.

Engineered Materials Segment

                                      Year Ended
                                      December 31,                         Percentage Change
($ in millions)             2021          2020          2019         2021 vs. 2020    2020 vs. 2019
Net sales                 $  755.0       $ 194.9       $ 209.9                 287 %            (7) %
Adjusted EBITDA           $   94.8       $  34.6       $  31.4                 174 %             10 %

Adjusted EBITDA margin 13 % 18 % 15 %

2021 vs. 2020



Of the $560.1 million, or 287%, increase in net sales, $468.4 million, or 240%,
was attributable to the contribution from the acquisitions of the PMMA business
and Aristech Surfaces. An additional 26% was attributable to increased sales
volumes, mostly due to higher sales to consumer electronics customers in Asia,
and an additional 19% was due to increased prices primarily from the pass
through of higher raw materials.

Adjusted EBITDA increased $60.2 million, or 174%, of which $71.0 million, or
206%, was attributable to the contribution from the acquisitions of the PMMA
business and Aristech Surfaces. Also contributing to the change was an increase
of 61% from increased sales volumes, mainly to consumer electronics customers in
Asia, offset by a decrease of 78% from lower margins due to higher raw materials
costs and a decrease of 12% due to higher fixed costs. During the fourth quarter
of 2021, including the acquired businesses, segment results were lower than
anticipated due to approximately $25.0 million of higher natural gas, freight,
and raw material costs, primarily due to an unprecedented, short-term spike

in
natural gas prices in Europe.

2020 vs. 2019

The 7% decrease in net sales was attributable to a 4% decrease in sales volume, due to COVID-19 impacts, as well as a 3% decrease in pricing from the pass through of lower raw material costs.



Adjusted EBITDA increased by $3.2 million, or 10%, compared to the prior year.
This increase was primarily due to a $4.2 million, or 13%, increase in margins,
primarily due to commercial excellence pricing actions. Also contributing to the
increase was a $0.8 million, or 2%, increase due to lower fixed costs. These
effects were partially offset by a decrease of $3.0 million, or 10%, from lower
sales volume.

Latex Binders Segment

                                       Year Ended
                                      December 31,                          Percentage Change
($ in millions)             2021           2020          2019         2021 vs. 2020    2020 vs. 2019
Net sales                 $ 1,183.4       $ 767.1       $ 902.8                  54 %           (15) %
Adjusted EBITDA           $   106.5       $  76.6       $  76.7                  39 %            (0) %
Adjusted EBITDA margin            9 %          10 %           8 %


2021 vs. 2020

The 54% increase in net sales was primarily due to a 46% increase in pricing from the pass through of raw material costs, mainly styrene and butadiene. Additionally, there was an increase of 6% due to increased sales volume for the



                                       46

  Table of Contents

period, which was driven by higher sales to CASE and paper applications, noting that sales volume to CASE applications alone increased 21% in comparison to prior year.


The $29.9 million, or 39%, increase in Adjusted EBITDA was primarily due to an
increase of $22.4 million, or 29%, in sales volume as discussed above. The
increase was also due to higher margins of $15.4 million, or 20%, including
impacts from commercial excellence initiatives. These effects were partially
offset by a decrease of $11.4 million, or 15%, due to higher fixed costs.

2020 vs. 2019

Of the 15% decrease in net sales, 15%, or nearly all of the decrease, was due to lower pricing from the pass through of lower raw material costs.



Adjusted EBITDA remained consistent year over year, with a minor decrease of
$0.1 million driven by several offsetting factors. There was a decrease of $6.4
million, or 8%, from a negative net timing variance as well as a decrease of
$2.0 million, or 3%, from lower volume and a decrease of $1.6 million, or 2%,
due to higher fixed costs. These decreases were partially offset by an increase
of $6.4 million, or 8%, mainly due to improved portfolio and product mix, as
well as commercial excellence actions, and an increase of $4.2 million, or 5%,
attributable to lower freight and utility costs.

Base Plastics Segment

                                        Year Ended
                                       December 31,                           Percentage Change
($ in millions)             2021           2020           2019          2021 vs. 2020    2020 vs. 2019
Net sales                 $ 1,497.9       $ 918.2       $ 1,156.3
       63 %           (21) %
Adjusted EBITDA           $   314.2       $ 106.0       $    98.7                 196 %              7 %
Adjusted EBITDA margin           21 %          12 %             9 %


2021 vs. 2020

Of the 63% increase in net sales, 53% was due to higher pricing from the pass
through of raw material costs, primarily styrene. Additionally, there was a 7%
increase due to higher sales volumes, mainly to building and construction
applications, and a 3% increase due to favorable foreign exchange rate impacts.

The $208.2 million, or 196%, increase in Adjusted EBITDA was primarily due to
higher margins, which contributed $167.3 million, or 158%, particularly in ABS
and PC products attributable to commercial excellence initiatives as well as
tight supply and strong demand. There was an additional increase of $26.0
million, or 25%, due to increased volumes as discussed above as well as an
increase of $12.5 million, or 12%, due to foreign exchange rate impacts.

2020 vs. 2019



Of the 21% decrease in net sales, 12% was due to lower sales volume, primarily
related to lower sales to automotive applications from COVID-19 impacts, and 10%
was due to lower pricing from the pass through of lower raw material costs.

Adjusted EBITDA increased by $7.3 million, or 7%, compared to the prior year. This increase was due to a $32.0 million, or 32%, increase in margins as a result of favorable pricing actions and tighter market conditions in the second



                                       47

  Table of Contents

half of the year. An additional $10.4 million, or 11%, increase was due to lower
fixed costs. These effects were partially offset by lower sales volume of $34.3
million, or 35%.

Polystyrene Segment

                                       Year Ended
                                      December 31,                          Percentage Change
($ in millions)             2021           2020          2019         2021 vs. 2020    2020 vs. 2019
Net sales                 $ 1,118.8       $ 698.9       $ 809.4
     60 %           (14) %
Adjusted EBITDA           $   183.1       $  79.4       $  54.4                 131 %             46 %
Adjusted EBITDA margin           16 %          11 %           7 %


2021 vs. 2020

Of the 60% increase in net sales, 65% was due to higher pricing primarily from
the pass through of higher styrene costs to our customers. This increase was
slightly offset by decreased sales volume of 5% caused by raw material
constraints and a planned production outage as well as higher demand in the
prior year for COVID-19 essential applications such as packaging.

The $103.7 million, or 131%, increase was due to higher margins resulting from
commercial excellence initiatives and tight market conditions, which resulted in
an increase of $119.5 million, or 150%. These effects were partially offset by a
decrease of $8.1 million, or 10%, from lower sales volume as noted above as well
as higher fixed costs resulting in a decrease of $5.9 million, or 7%.

2020 vs. 2019



Of the 14% decrease in net sales, 19% was due to lower pricing from the pass
through of lower styrene costs to our customers. This was partially offset by an
increase of 4% due to increased sales volume.

Adjusted EBITDA increased by $25.0 million, or 46%, compared to the prior year.
Higher margins, primarily from pricing initiatives and tighter market
conditions, resulted in a $22.4 million, or 41%, increase. Also contributing to
the increase was a $6.3 million, or 12%, increase in sales volume.

Feedstocks Segment

                                      Year Ended
                                     December 31,                         Percentage Change
($ in millions)            2021          2020          2019         2021 vs. 2020    2020 vs. 2019
Net sales                 $ 272.4       $ 165.5       $ 295.5                  65 %           (44) %
Adjusted EBITDA           $  33.7       $   3.2       $   6.5
  953 %           (51) %
Adjusted EBITDA margin         12 %           2 %           2 %


2021 vs. 2020

Of the 65% increase in net sales, 74% was due to higher pricing from the pass through of higher styrene prices. This effect was partially offset by a 10% decrease due to lower styrene-related sales volume.



The increase of $30.5 million in Adjusted EBITDA was primarily due to higher
styrene margins in Europe, despite significantly higher utility costs from high
natural gas prices, resulting in an increase of $41.3 million. This effect

was

                                       48

  Table of Contents

partially offset by negative impacts of $7.8 million due to foreign exchange rates as well as $2.2 million due to higher fixed costs.

2020 vs. 2019



Of the 44% decrease in net sales, 25% was due to lower styrene-related sales
volume and 19% was due to lower pricing from the pass through of lower styrene
prices.

Adjusted EBITDA decreased by $3.3 million, or 51%, compared to the prior year.
Lower margins resulted in a $4.8 million, or 74%, decrease due to unfavorable
net timing and portfolio mix. An additional 52% decrease was attributable to
currency impacts. These decreases were partially offset by lower fixed costs
driven by the Company's overall cost reduction initiatives, which resulted

in a
61% increase.

Americas Styrenics Segment

                             Year Ended
                            December 31,                    Percentage Change
($ in millions)      2021       2020       2019       2021 vs. 2020    2020 vs. 2019
Adjusted EBITDA*    $ 92.7     $ 67.0     $ 119.0                38 %           (44) %


*The results of this segment are comprised entirely of earnings from Americas
Styrenics, our equity method investment. As such, Adjusted EBITDA related to
this segment is included within "Equity in earnings of unconsolidated
affiliates" in the consolidated statements of operations.

2021 vs. 2020



The increase in Adjusted EBITDA was mainly due to increased polystyrene sales
volume and higher styrene and polystyrene margins in North America, primarily
attributable to COVID-19 related impacts in the prior year as well as tight
supply conditions caused by weather related and other events.

2020 vs. 2019


The 44% decrease in Adjusted EBITDA was mainly due to lower styrene margins in
North America, volume-related impacts from COVID-19, and the impact from the
planned turnaround at its St. James, Louisiana styrene facility in the first
quarter of 2020.

Outlook

Based on the strong demand in many of our end markets, as well as our commercial
excellence programs and the synergies from our acquired businesses, we expect
that 2022 will be another year of solid earnings and strong cash generation. As
discussed above in "2021 Highlights," there were challenges in late 2021 due to
high energy prices and adverse supply chain and production conditions, however,
we have navigated through these situations and have successfully continued
providing unique product solutions to our customers. We will continue to move
forward with our transformation strategy, including progressing on our process
to divest the styrenics businesses, and achieving our sustainability goals.

                         Non-GAAP Performance Measures

We present Adjusted EBITDA as a non-GAAP financial performance measure, which we
define as income from continuing operations before interest expense, net;
provision for income taxes; depreciation and amortization expense; loss on
extinguishment of long-term debt; asset impairment charges; gains or losses on
the dispositions of businesses and assets; restructuring charges; acquisition
related costs and other items. In doing so, we are providing management,

                                       49

Table of Contents

investors, and credit rating agencies with an indicator of our ongoing performance and business trends, removing the impact of transactions and events that we would not consider a part of our core operations.



There are limitations to using the financial performance measures such as
Adjusted EBITDA. This performance measure is not intended to represent net
income or other measures of financial performance. As such, it should not be
used as an alternative to net income as an indicator of operating performance.
Other companies in our industry may define Adjusted EBITDA differently than we
do. As a result, it may be difficult to use this or similarly-named financial
measures that other companies may use, to compare the performance of those
companies to our performance. We compensate for these limitations by providing a
reconciliation of this performance measure to our net income, which is
determined in accordance with accounting principles generally accepted in the
United States of America ("GAAP").

Adjusted EBITDA is calculated as follows for the years ended December 31, 2021,
2020, and 2019. Prior period amounts herein have been recast in conjunction with
adjustments made for the Company's classification of the Synthetic Rubber
business as discontinued operations.

                                                             Year Ended
                                                            December 31,
(in millions)                                       2021         2020        2019
Net income                                        $   440.0    $    7.9    $   92.0
Net income (loss) from discontinued
operations                                            160.4      (54.8)    

4.9


Net income from continuing operations                 279.6        62.7    

   87.1
Interest expense, net                                  79.4        43.6        39.3
Provision for income taxes                             70.9        42.7        12.7
Depreciation and amortization                         167.5        92.6        91.5
EBITDA(a)                                         $   597.4    $  241.6    $  230.6
Net gain on disposition of businesses and
assets                                                (0.6)       (0.4)    

(0.7)


Restructuring and other charges(b)                      9.0         5.6    

16.8


Acquisition transaction and integration net
costs (benefit)(c)                                     75.3         9.1    

(0.9)


Acquisition purchase price hedge loss
(gain)(d)                                              22.0       (7.3)    

-


Asset impairment charges or write-offs(e)               6.8        11.0    

      -
Other items(f)                                         19.5        25.5        55.4
Adjusted EBITDA                                   $   729.4    $  285.1    $  301.2

EBITDA is a non-GAAP financial performance measure that we refer to in making

operating decisions because we believe it provides our management as well as

our investors and credit agencies with meaningful information regarding the

Company's operational performance. We believe the use of EBITDA as a metric

assists our board of directors, management and investors in comparing our (a) operating performance on a consistent basis. Other companies in our industry

may define EBITDA differently than we do. As a result, it may be difficult to

use EBITDA, or similarly-named financial measures that other companies may

use, to compare the performance of those companies to our performance. We

compensate for these limitations by providing reconciliations of our EBITDA

results to our net income, which is determined in accordance with GAAP.

Restructuring and other charges for the years ended December 31, 2021, 2020,

and 2019 primarily relate to employee termination benefit charges as well as

contract termination charges incurred in connection with the Company's

transformational and corporate restructuring programs. Additionally, a

portion of the restructuring and other charges for the years ended December (b) 31, 2019 relate to decommissioning and employee termination benefit charges

incurred in connection with the upgrade and replacement of our compounding

facility in Terneuzen, The Netherlands as well as our decision to cease

manufacturing activities at our latex binders manufacturing facility in

Livorno, Italy. Refer to Note 21 in the consolidated financial statements for

further information regarding restructuring activities.


Note that the accelerated depreciation charges incurred as part of both the
Company's corporate restructuring program and the upgrade and replacement of the
Company's compounding facility in Terneuzen, The Netherlands are included within
the "Depreciation and amortization" caption above, and therefore are not
included as a separate adjustment within this caption.

                                       50

  Table of Contents

Acquisition transaction and integration net costs (benefit) for the years

ended December 31, 2021 and 2020 relate to expenses incurred for the PMMA

Acquisition and the Aristech Surfaces Acquisition. Acquisition transaction

and integration net benefit amounts for the year ended December 31, 2019 are (c) primarily comprised of the bargain purchase gain recorded in conjunction with

the Company's acquisition of latex binders production assets and related site


    infrastructure in Rheinmünster, Germany, partially offset by certain
    jurisdictional asset transfer taxes and advisory and professional fees
    incurred related to this acquisition.

The acquisition purchase price hedge loss (gain) for the years ended December

31, 2021 and 2020 relates to the change in fair value of the Company's (d) forward currency hedge arrangement that economically hedged the

euro-denominated purchase price of the PMMA business. Refer to Note 13 in the

consolidated financial statements for further information.

Asset impairment charges or write-offs for the years ended December 31, 2020 (e) relate to the impairment of the Company's styrene monomer assets in Boehlen,

Germany. Refer to Note 14 in the consolidated financial statements for
    further information.

Other items for the year ended December 31, 2021 primarily relate to fees

incurred in conjunction with certain of the Company's strategic initiatives,

including our ERP upgrade project. Other items for the years ended December

31, 2020 and 2019 primarily relate to advisory and professional fees incurred (f) in conjunction with our initiative to transition business services from Dow,

including certain administrative services such as accounts payable,

logistics, and IT services, which was substantially completed in 2020, as


    well as fees incurred in conjunction with certain of the Company's strategic
    initiatives.


                        Liquidity and Capital Resources

Cash Flows

The table below summarizes our primary sources and uses of cash for the years
ended December 31, 2021, 2020, and 2019. We have derived the summarized cash
flow information from our audited financial statements. Prior period amounts
herein have been recast in conjunction with adjustments made for the Company's
classification of the Synthetic Rubber business as discontinued operations, as
described in Note 5 of the consolidated financial statements and in Item
1-Business.

                                                                          Year Ended
                                                                         December 31,
(in millions)                                                   2021          2020         2019
Net cash provided by (used in):
Operating activities - continuing operations                 $     456.0    $   216.8    $   241.9
Operating activities - discontinued operations                     (3.3)         38.6         80.6
Operating activities                                               452.7        255.4        322.5
Investing activities - continuing operations                   (1,936.2)        (3.0)       (83.2)
Investing activities - discontinued operations                     396.5   

   (21.2)       (26.1)
Investing activities                                           (1,539.7)       (24.2)      (109.3)
Financing activities                                             1,075.7      (104.3)      (206.7)

Effect of exchange rates on cash                                   (4.4)   

4.4 (1.4) Net change in cash, cash equivalents, and restricted cash $ (15.7) $ 131.3 $ 5.1




Operating Activities

Net cash provided by operating activities from continuing operations during the
year ended December 31, 2021 totaled $456.0 million, driven by strong earnings,
and inclusive of dividends received from Americas Styrenics of $85.0 million.
Partially offsetting these factors was a $23.0 million reduction in operating
cash from a net working capital use during the period, primarily attributable to
increases in raw material costs. Net cash used in operating activities from
discontinued operations during the year ended December 31, 2021 totaled $3.3
million, and was related to the operations of our Synthetic Rubber business,
which was sold during the period. As discussed in Note 5 to the consolidated
financial statements, the sale of our Synthetic Rubber business excluded the
transfer of net working capital (excluding inventory).

                                       51

Table of Contents



As a result, the release of this working capital, the majority of which will
occur in the first quarter of 2022, is or will be included in our continuing
operating cash flows.

Net cash provided by operating activities from continuing operations during the
year ended December 31, 2020 totaled $216.8 million. This increase in cash was
driven by a $83.6 million increase in operating cash generated from a net
working capital release during the period, which was primarily attributable to
the Company's liquidity-focused actions during the height of the COVID-19
pandemic, including reduced capital spending, operating expenses, and working
capital, as well as the impact of lower raw material prices and sales volumes.
Net cash provided by operating activities from discontinued operations during
the year ended December 31, 2020 totaled $38.6 million, and was also driven by
the aforementioned liquidity-focused actions.

Net cash provided by operating activities from continuing operations during the
year ended December 31, 2019 totaled $241.9 million, inclusive of $110.0 million
of dividends received from Americas Styrenics. This increase in cash was driven
by a $98.6 million increase in operating cash generated from a net working
capital release during the period, which was primarily attributable to decreases
of $66.6 million in accounts receivable and $43.1 million in inventories, due to
lower raw material prices and lower sales volumes, as well as lower days sales
in inventory. Net cash provided by operating activities from discontinued
operations during the year ended December 31, 2019 totaled $80.6 million, and
was also driven by lower raw material prices and lower sales volumes during

the
period.

Investing Activities

Net cash used in investing activities from continuing operations during the year
ended December 31, 2021 totaled $1,936.2 million, which was primarily
attributable to net cash paid for asset or business acquisitions of $1,804.0
million (see Note 4), capital expenditures of $117.7 million, and payments for
the settlement of hedging instruments of $14.7 million (related to the
acquisition purchase price hedge - see Note 13). Net cash provided by investing
activities from discontinued operations during the year ended December 31, 2021
totaled $396.5 million, which was primarily attributable to cash received from
the sale of the Synthetic Rubber business.

Capital expenditures for 2022 are expected to be approximately $180.0 million, inclusive of spending for both growth initiatives as well as compliance and maintenance costs.


Net cash used in investing activities from continuing operations during the year
ended December 31, 2020 totaled $3.0 million. This activity included capital
expenditures of $66.6 million, partially offset by proceeds from the settlement
of hedging instruments of $51.6 million as well as proceeds of $11.9 million
from the sale of our former latex binders manufacturing facility in Livorno,
Italy. Net cash used in investing activities from discontinued operations during
the year ended December 31, 2020 totaled $21.2 million, which was attributable
to capital expenditures of $15.7 million as well as cash paid for a cost method
investment of $5.5 million.

Net cash used in investing activities from continuing operations during the year
ended December 31, 2019 totaled $83.2 million, primarily resulting from capital
expenditures of $84.0 million. Net cash used in investing activities from
discontinued operations during the year ended December 31, 2019 totaled $26.1
million, which was entirely attributable to capital expenditures.

Financing Activities



Net cash provided by financing activities during the year ended December 31,
2021 totaled $1,075.7 million. This activity was primarily due to $746.3 million
in proceeds from the issuance of the 2028 Term Loan B, $450.0 million in
proceeds from the issuance of the 2029 Senior Notes, and $11.0 million in
proceeds from exercise of option awards. This activity was partially offset by
$48.1 million of ordinary share repurchases, $35.4 million of deferred financing
fees paid, $14.6 million of net repayments of short-term borrowings, $21.9
million of dividend payments, and $10.7 million of net principal payments
related to our 2024 Term Loan B and 2028 Term Loan B during the period.

Net cash used in financing activities during the year ended December 31, 2020
totaled $104.3 million. This activity was primarily due to $61.8 million of
dividends paid, $25.0 million of payments related to the repurchase of ordinary
shares, $12.6 million net repayments of short-term borrowings, and $6.9 million
of net principal payments related to our 2024 Term Loan B during the period.
Additionally, net cash used in financing activities included $0.6 million of
withholding taxes paid related to the vesting of certain Restricted Share Units
("RSUs") during the period, which was more than offset by $2.6 million of
proceeds received from the exercise of option awards.

                                       52

Table of Contents



Net cash used in financing activities during the year ended December 31, 2019
totaled $206.7 million. This activity was primarily due to $119.7 million of
ordinary shares repurchases, $65.7 million of dividends paid, $7.0 million of
net principal payments related to our 2024 Term Loan B during the period, and
$10.6 million net repayments of short-term borrowings. Additionally, net cash
used in financing activities included $4.6 million of withholding taxes paid
related to the vesting of certain RSUs during the period, partially offset by
$0.9 million of proceeds received from the exercise of option awards.

Free Cash Flow



We use Free Cash Flow as a non-GAAP measure to evaluate and discuss the
Company's liquidity position and results. Free Cash Flow is defined as cash from
operating activities, less capital expenditures. We believe that Free Cash Flow
provides an indicator of the Company's ongoing ability to generate cash through
core operations, as it excludes the cash impacts of various financing
transactions as well as cash flows from business combinations that are not
considered organic in nature. We also believe that Free Cash Flow provides
management and investors with useful analytical indicator of our ability to
service our indebtedness, pay dividends (when declared), and meet our ongoing
cash obligations.

Free Cash Flow is not intended to represent cash flows from operations as
defined by GAAP, and therefore, should not be used as an alternative for that
measure. Other companies in our industry may define Free Cash Flow differently
than we do. As a result, it may be difficult to use this or similarly-named
financial measures that other companies may use, to compare the liquidity and
cash generation of those companies to our own. We compensate for these
limitations by providing a reconciliation to cash provided by operating
activities, which is determined in accordance with GAAP.

                                                     Year Ended
                                                   December 31,
(in millions)                              2021         2020        2019

Cash provided by operating activities $ 452.7 $ 255.4 $ 322.5 Capital expenditures

                       (123.5)      (82.3)      (110.1)
Free Cash Flow                           $   329.2    $  173.1    $   212.4

Refer to the discussion above for significant impacts to cash provided by operating activities for the years ended December 31, 2021, 2020, and 2019.

Capital Resources, Indebtedness and Liquidity



We require cash principally for day-to-day operations, to finance capital
investments and other initiatives, to purchase materials, to service our
outstanding indebtedness, and to fund the return of capital to shareholders via
dividend payments and ordinary share repurchases, when deemed appropriate. Our
sources of liquidity include cash on hand, cash flow from continuing operations,
and amounts available under the Senior Credit Facility and the Accounts
Receivable Securitization Facility (discussed further below).

As of December 31, 2021 and 2020, we had $2,368.8 million and $1,187.3 million,
respectively, in outstanding indebtedness and $1,064.1 million and $983.3
million, respectively, in working capital (calculated as current assets from
continuing operations less current liabilities from continuing operations). In
addition, as of December 31, 2021 and 2020, we had $560.6 million and $172.8
million, respectively, of foreign cash and cash equivalents on our consolidated
balance sheets, outside of our country of domicile, which was Ireland as of
December 31, 2021 and Luxembourg as of December 31, 2020, all of which is
readily convertible into other foreign currencies, including the U.S. dollar.
Our intention is not to permanently reinvest our foreign cash and cash
equivalents. Accordingly, we record deferred income tax liabilities related to
the unremitted earnings of our subsidiaries. For a detailed description of the
Company's debt structure, borrowing rates, and expected future payment
obligations, refer to Note 12 in the consolidated financial statements.

                                       53

Table of Contents



The following table outlines our outstanding indebtedness as of December 31,
2021 and 2020 and the associated interest expense, including amortization of
deferred financing fees and issuance discounts. Effective interest rates for the
borrowings included in the table below exclude the impact of deferred financing
fee amortization, certain other fees charged to interest expense (such as fees
for unused commitment fees during the period), and the impacts of derivatives
designated as hedging instruments.

                                   As of and for the Year Ended               As of and for the Year Ended
                                        December 31, 2021                           December 31, 2020
                                             Effective                                    Effective
                                             Interest      Interest                       Interest      Interest
($ in millions)                 Balance        Rate        Expense        Balance           Rate        Expense
Senior Credit Facility
2024 Term Loan B              $     670.4          2.1 %  $     20.6    $      677.3            2.6 %  $     23.3
2028 Term Loan B                    742.8          2.6 %        15.2               -              -             -
2026 Revolving Facility                 -            - %         2.1               -              -           3.7
2029 Senior Notes                   450.0          5.1 %        19.0               -              -             -
2025 Senior Notes                   500.0          5.4 %        20.7           500.0            5.4 %        19.5
Accounts Receivable
Securitization Facility                 -          2.0 %         1.8               -              -           1.5
Other indebtedness*                   5.6          2.2 %           -            10.0            2.4 %         0.1
Total                         $   2,368.8                 $     79.4    $    1,187.3                   $     48.1

*For the year ended December 31, 2021, interest expense on "Other indebtedness" totaled less than $0.1 million.



Our Senior Credit Facility includes the 2026 Revolving Facility, which matures
in May 2026 and has a borrowing capacity of $375.0 million. As of December 31,
2021, the Company had $368.6 million of funds available for borrowing (net of
$6.4 million outstanding letters of credit) under the 2026 Revolving Facility.
Further, as of December 31, 2021, the Company is required to pay a quarterly
commitment fee in respect of any unused commitments under the 2026 Revolving
Facility equal to 0.375% per annum.

Also included in our Senior Credit Facility is our 2024 Term Loan B (with
original principal of $700.0 million, maturing in September 2024), and our 2028
Term Loan B (with original principal of $750.0 million, maturing in May 2028),
each of which requires scheduled quarterly payments in amounts equal to 0.25% of
the original principal. The stated interest rate on our 2024 Term Loan B is
London Interbank Offered Rate ("LIBOR") plus 2.00% (subject to a 0.00% LIBOR
floor). The stated interest rate on our 2028 Term Loan B is LIBOR plus 2.50%
(subject to a 0.00% LIBOR floor). The Company made net principal payments of
$7.0 million on the 2024 Term Loan B and net principal payments of $3.7 million
on the 2028 Term Loan B during the year ended December 31, 2021, with an
additional $14.5 million of scheduled future payments classified within current
debt on the Company's consolidated balance sheet as of December 31, 2021 related
to both the 2024 Term Loan B and 2028 Term Loan B.

Our 2025 Senior Notes issued under the indenture executed in 2017 include $500.0
million aggregate principal amount of 5.375% senior notes that mature on
September 1, 2025. Interest on the 2025 Senior Notes is payable semi-annually on
May 3 and November 3 of each year. These Notes may be redeemed prior to their
maturity at the option of the Company under certain circumstances at specific
redemption prices. Refer to Note 12 in the consolidated financial statements for
further information.

Our 2029 Senior Notes, as issued under the indenture executed in 2021, include
$450.0 million aggregate principal amount of 5.125% senior notes that mature on
April 1, 2029. Interest on the 2029 Senior Notes is payable semi-annually on
February 15 and August 15 of each year, which commenced on August 15, 2021.
These Notes may be redeemed prior to their maturity at the option of the Company
under certain circumstances at specific redemption prices. Refer to Note 12 in
the consolidated financial statements for further information.

We also continue to maintain our Accounts Receivable Securitization Facility,
which has an outstanding borrowing capacity of $150.0 million. The Accounts
Receivable Securitization Facility was amended during 2021, and pursuant to the
amended terms, it matures in November 2024 and incurs fixed interest charges of
1.65% on outstanding borrowings plus variable commercial paper rates, as well as
fixed charges of 0.80% on available, but undrawn commitments. In August 2021, in
conjunction with the Aristech Surfaces Acquisition, we drew $150.0 million

on
our

                                       54

  Table of Contents

Accounts Receivable Securitization Facility, which was fully repaid as of
December 31, 2021. As such, as of December 31, 2021, there were no amounts
outstanding under this facility and the Company had approximately $150.0 million
of accounts receivable available to support this facility, based on the pool of
eligible accounts receivable. Refer to Note 12 in the consolidated financial
statements for further information on the facility.

Our ability to raise additional financing and our borrowing costs may be
impacted by short- and long-term debt ratings assigned by independent rating
agencies, which are based, in significant part, on our performance as measured
by certain credit metrics such as interest coverage and leverage ratios.

We and our subsidiaries, affiliates, or significant shareholders may from time
to time seek to retire or purchase our outstanding debt through cash purchases
in the open market, privately negotiated transactions, exchange transactions or
otherwise. Such repurchases or exchanges, if any, will depend on prevailing
market conditions, our liquidity requirements, contractual restrictions and
other factors. The amounts involved may be material.

Trinseo Materials Operating S.C.A. and Trinseo Materials Finance, Inc. (the
"Issuers" of our 2029 Senior Notes and 2025 Senior Notes and "Borrowers" under
our Senior Credit Facility) are dependent upon the cash generation and receipt
of distributions and dividends or other payments from our subsidiaries and joint
venture in order to satisfy their debt obligations. There are no known
significant restrictions by third parties on the ability of subsidiaries of the
Company to disburse or dividend funds to the Issuers and the Borrowers in order
to satisfy these obligations. However, as the Company's subsidiaries are located
in a variety of jurisdictions, the Company can give no assurances that our
subsidiaries will not face transfer restrictions in the future due to regulatory
or other reasons beyond our control.

The Senior Credit Facility and Indentures also limit the ability of the
Borrowers and Issuers, respectively, to pay dividends or make other
distributions to Trinseo PLC, which could then be used to make distributions to
shareholders. During the year ended December 31, 2021, the Company declared
total dividends of $0.80 per ordinary share, or $31.4 million, of which $13.6
million, inclusive of dividend equivalents, remains accrued as of December 31,
2021 and the majority of which was paid in January 2022. These dividends are
well within the available capacity under the terms of the restrictive covenants
contained in the Senior Credit Facility and Indentures. Further, significant
additional capacity continues to be available under the terms of these covenants
to support expected future dividends to shareholders, should the Company
continue to declare them.

The Company's cash flow generation in recent years has been strong, and the
Company generated positive cash flows during the year ended December 31, 2021.
We believe that funds provided by operations, our existing cash, cash
equivalent, and restricted cash balances, borrowings available under our 2026
Revolving Facility and our Accounts Receivable Securitization Facility will be
adequate to meet planned operating and capital expenditures for at least the
next 12 months under current operating conditions.

Our ability to generate cash from operations to pay our indebtedness and meet
other liquidity needs is subject to certain risks described herein and under
Item 1A-Risk Factors. As of December 31, 2021, we were in compliance with all
the covenants and default provisions under our debt agreements. Refer to Note 12
in the consolidated financial statements for further information on the details
of the covenant requirements.

We do not have any off-balance sheet financing arrangements that we believe are
reasonably likely to have a material current or future effect on our financial
condition, revenues or expenses, results of operations, liquidity, capital
expenditures or capital resources.

Contractual Obligations and Commercial Commitments



The Company's primary contractual obligations and commercial commitments consist
of the payments for principal and interest on our outstanding long-term debt,
raw material purchases, funding requirements under our pension and other
postretirement benefits, lease commitments, and obligations under our SAR SSAs.

The Company has both fixed and variable-rate long-term debt arrangements, which
have varying principal and interest payment requirements over their contractual
terms. Refer to the table and section above as well as to Note 12 in the
consolidated financial statements for more information on our debt arrangements.
Additionally, refer to Item 7A-

                                       55

Table of Contents



Quantitative and Qualitative Disclosures about Market Risk for discussion of our
interest rate and foreign currency risks related to our debt and debt-related
hedging arrangements.

The Company has certain raw material purchase contracts where we are required to
purchase certain minimum volumes at the then prevailing market prices. As of
December 31, 2021, the Company had $2,078.2 million of raw material purchase
obligations, of which $859.1 million is due within the next twelve months. These
commitments have remaining terms ranging from one to five years. Refer to Note
16 in the consolidated financial statements for more information on raw material
purchase commitments. Additionally, refer to Item 1 - Business - Sources and
Availability of Raw Materials for further description of the sources of our key
raw materials.

The Company has various pension and other postretirement plans. The Company is
required to make minimum contributions to certain of our funded pension plans
and is also obligated to make benefit payments to employees for the unfunded
pension plans and other postretirement plans. As of December 31, 2021, the
Company's estimated future benefit payments through 2031, reflecting expected
future service, as appropriate, was $137.5 million, of which $9.7 million is due
within the next twelve months. Refer to the section of our Critical Accounting
Policies and Estimates entitled "Pension Plans and Postretirement Benefits" for
more information on the factors impacting our pension and postretirement costs.
Additionally, refer to Note 17 in the consolidated financial statements for more
details on these employee benefit plans and the future payments expected to be
made for them through 2031.

The Company has operating and finance leases for certain of its plant and
warehouse sites, office spaces, rail cars, storage facilities, and equipment.
The Company's leases have remaining terms of one month through fourteen years.
As of December 31, 2021, the Company's estimated minimum commitments related to
our finance and operating lease obligations was $103.1 million, of which $23.1
million is due within the next twelve months. Refer to Note 24 in the
consolidated financial statements for further information on our lease portfolio
and future lease obligations.

As described in Item 1- Business- Our Relationship with Dow, the Company is
party to SAR SSAs with Dow, which are agreements under which Dow provides
certain site services to the Company at Dow-owned locations. Based on our
current year known costs and assuming that we continue with the SAR SSAs with
similar annualized costs going forward, we estimate our contractual obligations
under these agreements to be approximately $210.3 million annually for 2022
through 2026, and a total of $2,622.5 million thereafter through June 2039.
Refer to the aforementioned section of Item 1 for more information regarding
these agreements, including details regarding the rights of the Company and Dow
to terminate said agreements.

Derivative Instruments



The Company's ongoing business operations expose it to various risks, including
fluctuating foreign exchange rates and interest rate risk. To manage this risk,
the Company periodically enters into derivative financial instruments, such as
foreign exchange forward contracts and interest rate swap agreements. A summary
of these derivative financial instrument programs is described below; however,
refer to Note 13 of the consolidated financial statements for further
information. The Company does not hold or enter into financial instruments for
trading or speculative purposes.

Foreign Exchange Forward Contracts


Certain subsidiaries have assets and liabilities denominated in currencies other
than their respective functional currencies, which creates foreign exchange
risk. Our principal strategy in managing exposure to changes in foreign currency
exchange rates is to naturally hedge the foreign currency-denominated
liabilities on our consolidated balance sheets against corresponding assets of
the same currency such that any changes in liabilities due to fluctuations in
exchange rates are offset by changes in their corresponding foreign currency
assets. In order to further reduce our exposure, the Company uses foreign
exchange forward contracts to economically hedge the impact of the variability
in exchange rates on our assets and liabilities denominated in certain foreign
currencies. These derivative contracts are not designated for hedge accounting
treatment.

                                       56

  Table of Contents

Foreign Exchange Cash Flow Hedges



The Company also enters into forward contracts with the objective of managing
the currency risk associated with forecasted U.S. dollar-denominated raw
materials purchases by one of our subsidiaries whose functional currency is the
euro. By entering into these forward contracts, which are designated as cash
flow hedges, the Company buys a designated amount of U.S. dollars and sells
euros at the prevailing market rate to mitigate the risk associated with the
fluctuations in the euro-to-U.S. dollar foreign currency exchange rate.

Interest Rate Swaps



The Company enters into interest rate swap agreements to manage our exposure to
variability in interest payments associated with the Company's variable rate
debt. Under these interest rate swap agreements, which are designated as cash
flow hedges, the Company is effectively converting a portion of our variable
rate borrowings into a fixed rate obligation to mitigate the risk of variability
in interest rates.

Net Investment Hedge

The Company has certain fixed-for-fixed cross currency swaps ("CCS"), swapping
U.S. dollar principal and interest payments on our 2025 Senior Notes for
euro-denominated payments, which were designated as a hedge of the Company's net
investment in certain European subsidiaries under the forward method through
March 31, 2018 through the original CCS agreement entered into on September 1,
2017 ("2017 CCS"). As such, changes in their fair value, to the extent
effective, were recorded within the cumulative translation adjustment account as
a component of accumulated other comprehensive income or loss ("AOCI") through
March 31, 2018.

Effective April 1, 2018, in conjunction with the adoption of previously issued
hedging accounting guidance, the Company elected as an accounting policy to
re-designate the 2017 CCS as a net investment hedge (and any future similar
hedges) under the spot method. As such, changes in the fair value of the 2017
CCS that were included in the assessment of effectiveness (changes due to spot
foreign exchange rates) were recorded as cumulative foreign currency translation
within AOCI, and will remain in AOCI until either the sale or substantially
complete liquidation of the subsidiary. As an additional accounting policy
election applied to similar hedges under this standard, the initial value of any
component excluded from the assessment of effectiveness is recognized in income
using a systematic and rational method over the life of the hedging instrument.
Any difference between the change in the fair value of the excluded component
and amounts recognized in income under that systematic and rational method is
recognized in AOCI. The Company elected to amortize the initial excluded
component value as a reduction of "Interest expense, net" in the consolidated
statements of operations using the straight-line method over the remaining term
of the 2017 CCS. Additionally, the Company recognizes the accrual of periodic
USD and euro-denominated interest receipts and payments under the terms of CCS
arrangements, including the 2017 CCS, within "Interest expense, net" in the
consolidated statements of operations.

On February 26, 2020, the Company settled our 2017 CCS and replaced it with a
new CCS arrangement (the "2020 CCS") that carried substantially the same terms
as the 2017 CCS and also is designated as a net investment hedge under the spot
method. Upon settlement of the 2017 CCS, the Company realized net cash proceeds
of $51.6 million. The remaining $13.8 million unamortized balance of the initial
excluded component related to the 2017 CCS at the time of settlement is no
longer being amortized following the settlement and will remain in AOCI until
either the sale or substantially complete liquidation of the relevant
subsidiaries.

                   Critical Accounting Policies and Estimates

Our discussion and analysis of results of operations and financial condition are
based upon our financial statements, which have been prepared in accordance with
GAAP. The preparation of these financial statements requires us to make
estimates and judgments that affect the amounts reported. We base these
estimates and judgments on historical experiences and assumptions believed to be
reasonable under the circumstances. Actual results could vary from our estimates
under different conditions. Our significant accounting policies, which may be
affected by our estimates and assumptions, are more fully described in Note 2 in
the consolidated financial statements. An accounting policy is deemed to be
critical if it requires an accounting estimate to be made based on assumptions
about matters that are highly uncertain at the time the estimate is made, and if
different estimates that reasonably could have been used, or changes in the
accounting estimates that are reasonably likely to occur periodically, could
materially impact the financial

                                       57

Table of Contents

statements. The following critical accounting policies reflect our most significant estimates and assumptions used in the preparation of the consolidated financial statements.

Business Combinations and Asset Impairments

Business Combinations


Acquisitions that qualify as a business combination are accounted for using the
purchase accounting method. Amounts paid for an acquisition are allocated to the
assets acquired and liabilities assumed based on their fair value as of the date
of acquisition. Goodwill is recorded as the difference between the fair value of
the acquired assets and liabilities assumed (net assets acquired) and the
purchase price. Goodwill is not amortized, but is reviewed for impairment
annually as of October 1, or when events or changes in the business environment
indicate that the carrying value of a reporting unit may exceed its fair value.
Refer to the discussion below for further information on asset impairments.

Under the purchase accounting method, the Company completes valuation procedures
for an acquisition, often with the assistance of third-party valuation
specialists, to determine the fair value of the assets acquired and liabilities
assumed. These valuation procedures require management to make assumptions and
apply significant judgment to estimate the fair value of the assets acquired and
liabilities assumed. If the estimates or assumptions used should significantly
change, the resulting differences could materially affect the fair value of net
assets.

Specifically, the calculation of the fair value of tangible assets, including
property, plant and equipment, typically utilize the cost approach, which
computes the cost to replace the asset, less accrued depreciation resulting from
physical deterioration and functional and external obsolescence. The calculation
of the fair value of identified intangible assets is determined using cash flow
models following the income and cost approaches (or some combination thereof).
Significant inputs include estimated future cash flows, discount rates, royalty
rates, growth rates, sales projections, customer retention rates, and terminal
values, all of which require significant management judgment. Definite-lived
intangible assets, which are primarily comprised of customer relationships,
developed technology, tradenames, and software, are amortized over their
estimated useful lives using the straight-line method and are assessed for
impairment whenever events or changes in circumstances indicate the carrying
value of the asset may not be recoverable.

During the year ended December 31, 2021, the Company completed two significant
acquisitions: the PMMA Acquisition, closed on May 3, 2021, and the Aristech
Surfaces Acquisition, closed on September 1, 2021. Also, the Company completed
the divestiture of our Synthetic Rubber business on December 1, 2021. Refer to
Notes 4 and 5 in the consolidated financial statements for further information
on these transactions.

Asset Impairments

As of December 31, 2021, net property, plant and equipment, net identifiable
finite-lived intangible assets, and goodwill totaled $719.0 million, $823.8
million, and $710.1 million, respectively. Management makes estimates and
assumptions in preparing the consolidated financial statements for which actual
results will emerge over long periods of time. This includes the recoverability
of long-lived assets employed in the business. These estimates and assumptions
are closely monitored by management and periodically adjusted as circumstances
warrant. For instance, expected asset lives may be shortened or impairment may
be recorded based on a change in the expected use of the asset or performance of
the related asset group.

We evaluate long-lived assets and identifiable finite-lived intangible assets
for impairment whenever events or changes in circumstances indicate that the
carrying amount of an asset or asset grouping may not be recoverable. In the
event the carrying value of the asset exceeds its undiscounted future cash flows
and the carrying value is not considered recoverable, impairment may exist. An
impairment loss, if any, is measured as the excess of the asset's carrying value
over its fair value, generally based on a discounted future cash flow method,
independent appraisals, etc.

In connection with our strategy to focus efforts and increase investments in
certain product offerings serving specific applications that are less cyclical
and offer significantly higher growth and margin potential, and other management
considerations, in March of 2020, the Company initiated a consultation process
with the Economic Council and Works Councils of Trinseo Deutschland regarding
the disposition of our styrene monomer assets in Boehlen, Germany and our PBR
assets in Schkopau, Germany. The Company's assessments of these long-lived asset
groups for impairment indicated that the carrying values of the asset groups at
each location were not recoverable when compared to the expected undiscounted
future cash flows from the operation and potential disposition of these assets.
The fair

                                       58

  Table of Contents

value of the depreciable assets at each location was determined through an
analysis of the underlying fixed asset records in conjunction with the use of
industry experience and available market data. Based on the Company's
assessments, for the years ended December 31, 2021 and 2020, we recorded
impairment charges on the Boehlen styrene monomer assets of $5.8 million and
$11.1 million, respectively, which include charges recorded subsequent to March
2020 related to capital expenditures at the facility that we determined to be
impaired. The amounts are included within "Impairment charges" in the
consolidated statements of operations and are all allocated to the Feedstocks
segment.

During the year ended December 31, 2020, we also recorded impairment charges of
$28.0 million on the Schkopau PBR assets which are allocated to the Synthetic
Rubber business. As discussed below, during the second quarter of 2021 these
assets were classified as held-for-sale and their operating results were
classified as discontinued operations for all periods presented, along with the
rest of the Synthetic Rubber business.

Through December 31, 2021, we have continued to assess the recoverability of
certain assets, and concluded there are no additional significant events or
circumstances identified by management that would indicate these assets are not
recoverable. However, the current environment is subject to changing market
conditions and requires significant management judgment to identify the
potential impact to our assessment. If we are not able to achieve certain
actions or our future operating results do not meet our expectations, it is
possible that impairment charges may need to be recorded on one or more of our
operating facilities.

Long-lived assets to be disposed of by sale are classified as held-for-sale and
are reported at the lower of carrying amount or fair value less cost to sell,
and depreciation is ceased. Long-lived assets to be disposed of in a manner
other than by sale are classified as held-and-used until they are disposed. In
May 2021, the Company entered into an agreement to sell our Synthetic Rubber
business, as a result of which the assets and liabilities of the Synthetic
Rubber business were classified as held-for-sale in the consolidated balance
sheets starting in the second quarter of 2021, and have been reflected as such
for all periods presented until their disposal. The sale transaction was
completed in December 2021, thus as of December 31, 2021 these assets and
liabilities are no longer held-for-sale. Additionally, starting in the second
quarter of 2021, the operating results of the Synthetic Rubber business, net of
taxes, have been classified as discontinued operations in the consolidated
statements of operations for all periods presented. Refer to Note 5 for more
information.

As noted above, our goodwill impairment testing is performed annually as of
October 1 at a reporting unit level. We perform more frequent impairment tests
when events or changes in circumstances indicate that the fair value of a
reporting unit has more likely than not declined below its carrying value. As of
our annual assessment date of October 1, 2021, each of our reporting units had
fair values that exceeded the carrying value of their net assets, indicating
that no impairment of goodwill is warranted.

A goodwill impairment loss generally would be recognized when the carrying
amount of the reporting unit's net assets exceeds the estimated fair value of
the reporting unit. The estimated fair value of a reporting unit is determined
using a market approach and an income approach (under the discounted cash flow
method). When supportable, the Company employs the qualitative assessment of
goodwill impairment prescribed by Accounting Standards Codification 350. As of
December 31, 2021, our $710.1 million in total goodwill is allocated to our
reportable segments as follows: $667.3 million to Engineered Materials, $15.9
million to Latex Binders, $22.4 million to Base Plastics, and $4.5 million to
Polystyrene, with no amounts allocated to the Feedstocks or Americas Styrenics
segments. Of the $667.3 million of goodwill allocated to Engineered Materials,
$652.6 million was recorded at fair value on the date of acquisition related to
the PMMA business and Aristech Surfaces business acquired in 2021.

Factors which could result in future impairment charges, among others, include
changes in worldwide economic conditions, changes in technology, changes in
competitive conditions and customer preferences, and fluctuations in foreign
currency exchange rates. These factors are discussed in Item 7A-Quantitative and
Qualitative Disclosures about Market Risk and Item 1A- Risk Factors included in
this Annual Report.

Income Taxes

We account for income taxes using the asset and liability method. Under this
method, deferred tax assets and liabilities are recognized for the future tax
consequences of temporary differences between the carrying amounts and tax bases
of assets and liabilities using enacted rates. The effect of a change in tax
rates on deferred taxes is recognized in income in the period that includes

the
enactment date.

                                       59

  Table of Contents

Deferred taxes are provided on the outside basis differences and unremitted
earnings of subsidiaries outside of Ireland. All undistributed earnings of
foreign subsidiaries and affiliates are expected to be repatriated as of
December 31, 2021. Based on the evaluation of available evidence, both positive
and negative, we recognize future tax benefits, such as net operating loss
carryforwards and tax credit carryforwards, to the extent that realizing these
benefits is considered to be more likely than not.

As of December 31, 2021, we had deferred tax assets of $122.6 million, after
valuation allowances of $127.7 million. In evaluating the ability to realize the
deferred tax assets, we rely on, in order of increasing subjectivity, taxable
income in prior carryback years, the future reversals of existing taxable
temporary differences, tax planning strategies and forecasted taxable income
using historical and projected future operating results.

Swiss federal and cantonal tax reform was enacted on August 6, 2019 and October
25, 2019, respectively, and includes measures such as, the elimination of
certain preferential tax regimes and implementation of new tax rates at both the
federal and cantonal levels. It also includes transitional relief measures which
may provide for future tax deductions. As a result of both the federal and
cantonal law changes, the Company recorded a $65.0 million one-time deferred tax
benefit for the year ended December 31, 2019, of which $61.6 million was related
to cantonal tax law changes. The Company believes it is more likely than not
that a portion of this deferred tax benefit recorded as a result of these
cantonal tax law changes will not be realized during the utilization period
provided by the legislation, spanning 2025 through 2029. This is based on the
Company's estimate of future taxable income in Switzerland, which was determined
using management's judgment and assumptions about various factors, such as:
historical experience and results, cyclicality of the business, implications of
COVID-19, recent acquisitions and divestitures, and future industry and
macroeconomic conditions and trends possible during the aforementioned
utilization period. As a result, the Company recorded a $25.3 million valuation
allowance as of December 31, 2019. As of December 31, 2021, due to foreign
exchange translation, the total valuation allowance recorded was $25.8 million.

As of December 31, 2021, we had deferred tax assets for tax loss carryforward of
approximately $389.4 million, $17.4 million of which is subject to expiration in
the years between 2022 and 2027. We continue to evaluate our historical and
projected operating results for several legal entities for which we maintain
valuation allowances on net deferred tax assets.

We are subject to income taxes in Ireland, the United States and numerous
foreign jurisdictions, and are subject to audit within these jurisdictions.
Therefore, in the ordinary course of business there is inherent uncertainty in
quantifying our income tax positions. The tax provision includes amounts
considered sufficient to pay assessments that may result from examinations of
prior year tax returns; however, the amount ultimately paid upon resolution of
issues raised may differ from the amounts accrued. Since significant judgment is
required to assess the future tax consequences of events that have been
recognized in our financial statements or tax returns, the ultimate resolution
of these events could result in adjustments to our financial statements and such
adjustments could be material. Therefore, we consider such estimates to be
critical in preparation of our financial statements.

The financial statement effect of an uncertain income tax position is recognized
when it is more likely than not, based on the technical merits, that the
position will be sustained upon examination. Accruals are recorded for other tax
contingencies when it is probable that a liability to a taxing authority has
been incurred and the amount of the contingency can be reasonably estimated.
Uncertain income tax positions have been recorded in "Other noncurrent
obligations" in the consolidated balance sheets for the periods presented.

Management judgment is required in determining our provision for income taxes,
our deferred tax assets and liabilities, and any valuation allowance recorded
against our deferred tax assets. The valuation allowance is based on our
estimates of future taxable income and the period over which we expect the
deferred tax assets to be recovered. Our estimate of future taxable income is
based on management's judgment and assumptions about various factors including
historical experience and results, cyclicality of the business, and future
industry and macroeconomic conditions and trends. Changes in these assumptions
in future periods may require we adjust our valuation allowance, which could
materially impact our financial position and results of operations.

Pension Plans and Postretirement Benefits



We have various company-sponsored retirement plans covering substantially all
employees. We also provide certain health care and life insurance benefits to
retired employees in the United States. The U.S.-based plans provide health care
benefits, including hospital, physicians' services, drug and major medical

expense coverage, and life

                                       60

  Table of Contents

insurance benefits. We recognize the underfunded or overfunded status of a
defined benefit pension or postretirement plan as an asset or liability in our
consolidated balance sheets and recognize changes in the funded status in the
year in which the changes occur through AOCI, which is a component of
shareholders' equity.

A settlement is a transaction that is an irrevocable action that relieves the
employer (or the plan) of primary responsibility for a pension or postretirement
benefit obligation, and that eliminates significant risks related to the
obligation and the assets used to effect the settlement. The Company does not
record settlement gains or losses during interim periods when the cost of all
settlements in a year is less than or equal to the sum of the service cost and
interest cost components of net periodic benefit cost for the plan in that year.

Pension benefits associated with these plans are generally based on each
participant's years of service, compensation, and age at retirement or
termination. The discount rate is an important element of expense and liability
measurement. We evaluate our assumptions at least once each year, or as facts
and circumstances dictate, and make changes as conditions warrant.

We determine the discount rate used to measure plan liabilities as of the
December 31 measurement date for the pension and postretirement benefit plans.
The discount rate reflects the current rate at which the associated liabilities
could be effectively settled at the end of the year. We set our discount rates
to reflect the yield of a portfolio of high quality, fixed-income debt
instruments that would produce cash flows sufficient in timing and amount to
settle projected future benefits.

We use a full yield curve approach in the estimation of the future service and
interest cost components of net periodic benefit cost for our defined benefit
pension and other postretirement benefit plans by applying the specific spot
rates along the yield curve used in the determination of the benefit obligation
to the relevant projected cash flows. Service cost related to our defined
benefit pension plans and other postretirement plans is included within "Cost of
sales" and "Selling, general and administrative expenses," whereas all other
components of net periodic benefit cost are included within "Other expense, net"
in the consolidated statements of operations.

We determine the expected long-term rate of return on assets by performing an
analysis of historical and expected returns based on the underlying assets,
which generally are insurance contracts. We also consider our historical
experience with the pension fund asset performance. The expected return of each
asset class is derived from a forecasted future return confirmed by current and
historical experience. Future actual net periodic benefit cost will depend on
the performance of the underlying assets and changes in future discount rates,
among other factors.

The weighted average assumptions used to determine pension plan obligations and net periodic benefit costs are provided below:



                                                         Non-U.S. Defined           U.S. Defined Benefit        Other Postretirement
                                                       Benefit Pension Plans         Pension Plans (1)              Benefit Plans
                                                           December 31,                 December 31,                December 31,
                                                        2021           2020          2021          2020          2021           2020

Pension and other postretirement plan obligations: Discount rate for projected benefit obligation / accumulated postretirement benefit obligation

              1.10 %        

0.74 % 2.92 % N/A 2.90 % 3.11 % Net periodic benefit costs: Discount rate for service cost

                             0.78 %        

1.04 % 3.20 % N/A 3.32 % 3.61 % Discount rate for interest cost

                            0.57 %        

0.79 % 2.37 % N/A 2.34 % 3.08 % Expected long-term rate of return on plan assets

           0.66 %        0.82 %        5.89 %         N/A           N/A            N/A


The Company's U.S. defined benefit pension plans were acquired in 2021, (1) primarily in conjunction with the PMMA Acquisition, and as such, there were

no assumptions used to determine pension plan obligations or net periodic

benefit costs as of and for the year ended December 31, 2020.




Holding all other factors constant, a 0.25% increase (decrease) in the discount
rate used to determine net periodic benefit cost would decrease (increase) 2022
pension expense for our non-U.S. plans by approximately $1.5 million and $(1.5)
million, respectively. Holding all other factors constant, a 0.25% increase
(decrease) in the long-term rate of return on assets used to determine net
periodic benefit cost for our non-U.S. plans would decrease (increase) 2022
pension expense by approximately $0.1 million and $(0.1) million, respectively.
Holding all other factors constant, a 0.25%

                                       61

Table of Contents


increase or decrease in the discount rate, or the long-term rate of return on
assets, used to determine net periodic benefit cost for our U.S. plans would
change our 2022 pension expense by less than $0.1 million.

Plan assets totaled $157.1 million as of December 31, 2021 and 2020. As noted
above, plan assets are invested primarily in insurance contracts that provide
for guaranteed returns. Investments in the pension plan insurance contracts are
valued utilizing unobservable inputs, which are contractually determined based
on returns, fees, and the present value of the future cash flows, or cash
surrender values, of the contracts, and are classified as Level 3
investments. The Company presents certain pension plan assets valued at net
asset value per share as a practical expedient outside of the fair value
hierarchy.

                        Recent Accounting Pronouncements

We describe the impact of recent accounting pronouncements in Note 2 of the consolidated financial statements, included elsewhere within this Annual Report.

© Edgar Online, source Glimpses